CytoDyn Inc. CYDY
0.25 USD +0.01 (+4.17%)
Regular-session close
0.24 Day range 0.2533
0.18 52-week range 0.40
- YTD
- -10.71%
- 1 year
- 0.00%
- Market cap
- 367.38M
- EPS (ttm)
- -0.03
- YTD return
- -10.71%
- 1-year return
- 0.00%
- Volume
- 976.73K
- Avg volume
- 1.85M
- Open
- 0.2413
- Previous close
- 0.24
- Day's range
- 0.24 – 0.2533
- 52-week range
- 0.18 – 0.40
5D +0.0199 (+8.65%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 21, 2025 | Nov 1, 2024 | 0.00 | — | — | — |
| Oct 15, 2024 | Aug 1, 2024 | 0.00 | 0.02 | — | — |
| Aug 15, 2024 | May 1, 2024 | 0.00 | -0.02 | — | — |
| Apr 15, 2024 | Feb 1, 2024 | 0.00 | -0.01 | — | — |
| Jan 16, 2024 | Nov 1, 2023 | 0.00 | -0.01 | — | — |
| Oct 23, 2023 | Aug 1, 2023 | 0.00 | -0.01 | — | — |
News
CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors 
CytoDyn and QLHC Advance Leronlimab into Two New PRE-I-SPY Studies in Metastatic Triple-Negative Breast Cancer 
Stocks That Hit 52-Week Highs On Tuesday 
Stocks That Hit 52-Week Highs On Tuesday 
Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on CYDY — it syncs with the Stock Master app.